The private sector will drive the demand for higher quality and new technology, but with the government focussing on public private partnerships, growth and quality improvement can be nurtured across both the sectors," says Frost & Sullivan Research Analyst Sandhya Miseer. "The Government's policies pertaining to the new national health insurance (NHI) scheme will also significantly influence growth opportunities."

 New analysis from Frost & Sullivan (medicaldevices.frost.com), South African Intravenous Therapy Devices Market, finds that the market earned revenues of $151.0 million in 2009 and estimates this to reach $205.3 million in 2016.  If you are interested in more information on this study, please send an email to Patrick Cairns, Corporate Communications, at patrick.cairns[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country.

 Read more:-